AOD9604 and Energy Balance Research In obese ob/ob and lean C57BL/6J mice treated for 14 days via mini-osmotic pumps, AOD9604 significantly reduced body weight gain in obese mice, associated with increased in vivo fat oxidation and increased plasma glycerol levels as an index of enhanced lipolysis without the hyperglycaemia or reduced insulin secretion associated with intact hGH treatment
doi: 10.1111/j.1468-1293.2010.00906.x
ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article
While we strive to keep our content current with the latest research and clinical guidelines, it is intended for general informational purposes only
Minimizing Pain and Enhancing Comfort While B12 injections are generally well tolerated, the technique can make all the difference